Chinese-funded brokerages leading the IPO boom in Hong Kong stocks: Sponsorship numbers and market share at the forefront

Mars Finance News: On April 29, it was reported that the Hong Kong IPO market is seeing a strong recovery in 2025. Throughout the year, both the number of new shares listed and the fundraising scale are rising at the same time. The total amount raised is approaching 290 billion Hong Kong dollars, returning to the global No. 1 position after 4 years. Entering 2026, this heat continues to surge. On April 28, as “the world’s first AI optical computing and power stock,” Xizhi Technology, and “the first A to H 18A stock,” Maiwei Biotech, listed on the Hong Kong Stock Exchange on the same day, a total of 47 companies have successfully gone public in Hong Kong this year, raising nearly 140 billion Hong Kong dollars in aggregate. What’s more, there are currently as many as 434 companies in the pipeline. Overall, the Hong Kong IPO business shows three distinct features: (1) A-share companies’ listings in Hong Kong continue to heat up, with hard technology and biopharmaceuticals becoming the main sectors; (2) Chinese-funded securities firms are far ahead in both the number of sponsors and market share, and leading institutions are accelerating their deployment in overseas investment-banking ecosystems; and (3) project reserves remain robust, with a shortage of both sponsored-issuance support and cross-border, hybrid professional talent—becoming a key factor in competition in the industry. (Shanghai Securities News)